We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+0.74%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$7.26B
AUM Growth
-$991M
(-12%)
Cap. Flow
-$861M
Cap. Flow
% of AUM
-11.85%
Top 10 Holdings %
Top 10 Hldgs %
17.28%
Holding
1,731
New
11
Increased
301
Reduced
1,277
Closed
139
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pentair
PNR
|
+$11.7M |
| 2 |
Archer Daniels Midland
ADM
|
+$11.3M |
| 3 |
Nucor
NUE
|
+$10.5M |
| 4 |
Dover
DOV
|
+$10.2M |
| 5 |
Brown-Forman Class B
BF.B
|
+$9.25M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$49.6M |
| 2 |
Microsoft
MSFT
|
+$36.8M |
| 3 |
CB
CHUBB CORPORATION
CB
|
+$30.3M |
| 4 |
Gilead Sciences
GILD
|
+$23.6M |
| 5 |
Amgen
AMGN
|
+$22.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.22% |
| 2 | Technology | 14.93% |
| 3 | Financials | 13.79% |
| 4 | Consumer Staples | 9.84% |
| 5 | Communication Services | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SVU
1151
DELISTED
SUPERVALU Inc.
SVU
| $342K | ﹤0.01% |
8,489
-3,495
| -29% | -$124K |
|
1152
Bio-Rad Laboratories Class A
BIO
$8.42B
| $336K | ﹤0.01% |
2,458
-236
| -9% | -$31K |
|
1153
Darling Ingredients
DAR
$9.93B
| $336K | ﹤0.01% |
25,514
-3,942
| -13% | -$39.7K |
|
|
RPTP
1154
DELISTED
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
| $336K | ﹤0.01% |
72,950
-7,206
| -9% | -$29K |
|
1155
Cirrus Logic
CRUS
$6.74B
| $335K | ﹤0.01% |
9,208
-1,605
| -15% | -$52K |
|
|
SGNT
1156
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
| $335K | ﹤0.01% |
27,529
-2,654
| -9% | -$37.2K |
|
1157
ITT
ITT
$17.5B
| $334K | ﹤0.01% |
9,058
+236
| +3% | +$8.04K |
|
1158
Live Nation Entertainment
LYV
$41.2B
| $334K | ﹤0.01% |
14,974
+507
| +4% | +$11.1K |
|
|
HRC
1159
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $334K | ﹤0.01% |
6,639
-708
| -10% | -$33.4K |
|
|
EFII
1160
DELISTED
Electronics for Imaging
EFII
| $334K | ﹤0.01% |
7,887
-1,512
| -16% | -$61.7K |
|
1161
Generac Holdings
GNRC
$11.9B
| $333K | ﹤0.01% |
8,933
-1,566
| -15% | -$50.5K |
|
1162
Collegium Pharmaceutical
COLL
$1.14B
| $332K | ﹤0.01% |
18,313
+708
| +4% | +$12.9K |
|
1163
Axalta
AXTA
$7.01B
| $331K | ﹤0.01% |
11,338
-135
| -1% | -$3.43K |
|
1164
Cognex
CGNX
$10.3B
| $331K | ﹤0.01% |
17,012
+284
| +2% | +$4.95K |
|
1165
Kirby Corp
KEX
$7.95B
| $331K | ﹤0.01% |
5,491
+167
| +3% | +$9.11K |
|
1166
Monro
MNRO
$525M
| $331K | ﹤0.01% |
4,633
-795
| -15% | -$52.6K |
|
|
KATE
1167
DELISTED
Kate Spade & Company
KATE
| $331K | ﹤0.01% |
12,961
+172
| +1% | +$3.38K |
|
1168
FTI Consulting
FCN
$4.82B
| $330K | ﹤0.01% |
9,307
-884
| -9% | -$29.6K |
|
|
AVDL
1169
DELISTED
Avadel Pharmaceuticals
AVDL
| $329K | ﹤0.01% |
29,786
-2,560
| -8% | -$25.4K |
|
1170
Five Below
FIVE
$11.2B
| $327K | ﹤0.01% |
7,918
-1,364
| -15% | -$49.8K |
|
|
HA
1171
DELISTED
Hawaiian Holdings, Inc.
HA
| $327K | ﹤0.01% |
6,928
-1,192
| -15% | -$46.2K |
|
|
ELLI
1172
DELISTED
Ellie Mae Inc
ELLI
| $326K | ﹤0.01% |
3,599
-681
| -16% | -$50.9K |
|
|
SLCA
1173
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $325K | ﹤0.01% |
14,300
+638
| +5% | +$11.8K |
|
|
VSTO
1174
DELISTED
Vista Outdoor Inc.
VSTO
| $325K | ﹤0.01% |
6,253
+13
| +0.2% | +$627 |
|
1175
ANI Pharmaceuticals
ANIP
$1.77B
| $324K | ﹤0.01% |
9,611
-962
| -9% | -$32.6K |
|
Similar funds
ProShare Advisors's Q1 2016 Portfolio in Review
As of Q1 2016, ProShare Advisors held 1,731 positions worth $7.26B, down 12% from $8.26B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
ProShare Advisors withdrew a net $861M in Q1 2016, closing 139 positions and reducing 1,277 holdings. Its most notable exit was CHUBB CORPORATION, an estimated $30.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 19% a quarter earlier, followed by Technology and Financials.
Against the trend, ProShare Advisors opened a new position in ProShares Managed Futures Strategy ETF worth $5.35M.
- ProShare Advisors's largest Q1 2016 buy was ProShares Managed Futures Strategy ETF: 134,581 shares worth $5.35M.
- ProShare Advisors added most to Pentair in Q1 2016, an estimated $11.7M increase.
- ProShare Advisors's biggest Q1 2016 reduction was Apple, cutting an estimated $49.6M.
- ProShare Advisors fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $30.3M.
- ProShare Advisors's ten largest holdings make up 17% of its $7.26B portfolio in Q1 2016.
- ProShare Advisors opened 11 new positions and closed 139 in Q1 2016.
- ProShare Advisors's portfolio value fell 12% quarter-over-quarter to $7.26B.
Based on ProShare Advisors's 13F filing for Q1 2016, filed 6 May 2016.